Kayeong Lim

Korea Institute of Brain Science — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index2.6kcitations51works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(45), Advanced biosensing and bioanalysis techniques(12), RNA regulation and disease(9), RNA and protein synthesis mechanisms(8), Mitochondrial Function and Pathology(4)

Publications51 total

High-efficiency base editing for nuclear and mitochondrial DNA with an optimized DYW-like deaminase
Molecular Therapy·2025· 1 citedOpen Access
Data from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S6 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S5 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S10 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Table S2 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S15 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S4 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Table S1 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Table S3 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S12 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S1 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S3 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S7 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S11 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S13 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Table S4 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S2 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S8 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
Figure S14 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells
2025Open Access
page 1 of 3Next →

Frequent Co-authors

Heon Seok Kim(22), Soyoung Lee(20), Kyunghwan Kim(20), Hye‐Jin Jeong(20), Subin Choi(20), Himchan Cheng(20), Dayoung Kim(20), Soomin Heo(20), Jinhee Mun(20), Minjong Kim(20), Eunjin Lee(20), Yoon Ji Choi(20), Seon‐gyeong Lee(20), Eun A Lee(20), Yewon Jang(20), Euihwan Jeong(20), Seung‐Jae Myung(20), Deok‐Beom Jung(20), Chang Sik Yu(20), In Ho Song(20)